(VIANEWS) – MONTEA (MONT.BR), KONGSBERG GRUPPEN (KOG.OL), SANOFI (SAN.PA) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. MONTEA (MONT.BR)
13.3% sales growth and 11.22% return on equity
Montea NV is a public regulated real estate company under Belgian law (GVV/SIR) that specializes in logistics real estate in Belgium, the Netherlands, France, and Germany. The company is a benchmark player in this market. Montea literally offers its customers the space to grow through versatile and innovative property solutions. In this way, Montea creates value for its shareholders. As of 31/12/2023 the property portfolio represented a total surface of 1,959,242 m², spread across 95 locations. Montea NV has been listed on Euronext Brussels (MONT) and Euronext Paris (MONTP) since the end of 2006.
Earnings Per Share
As for profitability, MONTEA has a trailing twelve months EPS of €8.31.
PE Ratio
MONTEA has a trailing twelve months price to earnings ratio of 9.48. Meaning, the purchaser of the share is investing €9.48 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.22%.
More news about MONTEA.
2. KONGSBERG GRUPPEN (KOG.OL)
10.6% sales growth and 29.09% return on equity
Kongsberg Gruppen ASA, together with its subsidiaries, provides high-tech systems and solutions primarily to customers in the maritime and defense markets. The company operates through three segments: Kongsberg Maritime, Kongsberg Defence & Aerospace, and Other. The Kongsberg Maritime segment offers solutions and systems for bridge and control systems, which include dynamic positioning, propulsion control, and navigation, as well as automation systems; energy solutions and ship design services; and propellers, thrusters, water jet systems, and systems for offshore manoeuvring of maritime vessels. This segment also provides winches for mooring, anchor handling, and special systems for offshore vessels, tugs, marine vessels, and various other classes of vessel, as well as cranes; hydroacoustics; autonomous underwater vessels and solutions for autonomous maritime vessels; and products related to fisheries, systems for underwater mapping, and sensors and solutions for specialist vessels. The Kongsberg Defence & Aerospace segment offers various systems and services to the defense industry. It provides air defense and combat systems, sonars, and navigation for marine vessels and submarines, as well as integrated command and control systems; remote tower solutions for airports; remote control weapon stations for land-based vehicles and marine vessels; products for military tactical communication; naval strike and air-to-surface missiles; and lightweight composite and titanium components for F-35 combat aircraft. This segment also offers components and services to the space industry, as well as port monitoring systems; and maintenance, repair, and overhaul services. The Other segment focuses on digitalization within the oil and gas, wind, and merchant marine markets. It operates primarily in Norway, Europe, North America, South America, Asia, Australia, and South Africa. Kongsberg Gruppen ASA was founded in 1814 and is headquartered in Kongsberg, Norway.
Earnings Per Share
As for profitability, KONGSBERG GRUPPEN has a trailing twelve months EPS of kr25.62.
PE Ratio
KONGSBERG GRUPPEN has a trailing twelve months price to earnings ratio of 41.22. Meaning, the purchaser of the share is investing kr41.22 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.09%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 20.5%, now sitting on 44.95B for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 25.5% and 22.6%, respectively.
Sales Growth
KONGSBERG GRUPPEN’s sales growth is 19.5% for the current quarter and 10.6% for the next.
Yearly Top and Bottom Value
KONGSBERG GRUPPEN’s stock is valued at kr1,056.00 at 22:20 EST, under its 52-week high of kr1,123.00 and way higher than its 52-week low of kr435.60.
More news about KONGSBERG GRUPPEN.
3. SANOFI (SAN.PA)
7.4% sales growth and 5.82% return on equity
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €4.3.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 21.15. Meaning, the purchaser of the share is investing €21.15 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.82%.
Yearly Top and Bottom Value
SANOFI’s stock is valued at €90.96 at 22:20 EST, way below its 52-week high of €104.32 and way higher than its 52-week low of €80.60.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 5.2% and positive 0.8% for the next.
More news about SANOFI.
4. SPBK1 ØSTFOLD AKE (SOAG.OL)
7.3% sales growth and 12.1% return on equity
SpareBank 1 Østfold Akershus, a savings bank, provides various banking products and services. The company offers savings, operating, tax deduction, deposit, placement, and currency accounts; and savings and investment products. It also provides consumer, construction, repayment, boat, motorcycle, and car loans; operating credit products; bank guarantees; operating credit for agriculture; mortgage products; leasing and factoring services. In addition, the company offers various insurance products, such as vehicle, house and travel, personal, animal, liability, work machine, interruption, condominium, cyber, movable property, commercial building, project, transport, crime, bus, group life, health, leisure accident, occupational injury, accident insurance children, and sick pay insurance products; and pension products. Further, it provides credit, municipal payment, and other bank cards; payment terminal, debt collection, and document collection services; bonds, forwards, and currency options; invoice automatic, eGiro/Cremul, KID invoice, and OCR and eGiro payment services; and mobile and online banking services. SpareBank 1 Østfold Akershus was founded in 1835 and is headquartered in Moss, Norway.
Earnings Per Share
As for profitability, SPBK1 ØSTFOLD AKE has a trailing twelve months EPS of kr38.26.
PE Ratio
SPBK1 ØSTFOLD AKE has a trailing twelve months price to earnings ratio of 9.44. Meaning, the purchaser of the share is investing kr9.44 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.1%.
Sales Growth
SPBK1 ØSTFOLD AKE’s sales growth for the next quarter is 7.3%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 34.7% and 17.7%, respectively.
Yearly Top and Bottom Value
SPBK1 ØSTFOLD AKE’s stock is valued at kr361.00 at 22:20 EST, higher than its 52-week high of kr343.00.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Mar 22, 2024, the estimated forward annual dividend rate is 21.5 and the estimated forward annual dividend yield is 6.27%.
More news about SPBK1 ØSTFOLD AKE.
5. CREDIT AGRICOLE (ACA.PA)
6.1% sales growth and 7.17% return on equity
Crédit Agricole S.A. provides retail, corporate, insurance, and investment banking products and services in France and internationally. It operates through French Retail Banking – Regional Banks; French Retail Banking – LCL; International Retail Banking; Asset Gathering; Large Customers; and Specialised Financial Services segments. The company offers banking products and services, finance, savings, wealth management, payment, and cash flow management services; consumer finance products; savings/retirement, death and disability/creditor/group, and property and casualty insurance products; investment solutions; and banking and specialized financial services. It also provides investment banking, structured finance, international trade finance, commercial banking, capital market, and syndication services; financing solutions for property and equipment investment and renewal requirements; trade receivable financing and management solutions for corporates; asset servicing solutions for investment products, as well as various asset classes, such as execution, clearing, forex, security lending and borrowing, custody, depositary bank, fund administration, middle-office outsourcing solutions, and fund distribution support and issuer services; and online banking services. The company serves retail customers, corporates, banks and financial institutions, government agencies, and local authorities. Crédit Agricole S.A. was founded in 1894 and is headquartered in Montrouge, France. Crédit Agricole S.A. operates as a subsidiary of SAS Rue La Boetie.
Earnings Per Share
As for profitability, CREDIT AGRICOLE has a trailing twelve months EPS of €1.94.
PE Ratio
CREDIT AGRICOLE has a trailing twelve months price to earnings ratio of 7.12. Meaning, the purchaser of the share is investing €7.12 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.17%.
Volume
Today’s last reported volume for CREDIT AGRICOLE is 5518710 which is 18.64% above its average volume of 4651440.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on May 29, 2024, the estimated forward annual dividend rate is 1.05 and the estimated forward annual dividend yield is 7.42%.
Sales Growth
CREDIT AGRICOLE’s sales growth is 3.3% for the ongoing quarter and 6.1% for the next.
Yearly Top and Bottom Value
CREDIT AGRICOLE’s stock is valued at €13.82 at 22:20 EST, way below its 52-week high of €15.93 and way higher than its 52-week low of €11.05.
More news about CREDIT AGRICOLE.
